Mengis Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $962K | Sell |
13,394
-600
| -4% | -$46.2K | 0.17% | 117 |
|
|
2025
Q4 | $1.11M | Sell |
13,994
-3,361
| -19% | -$265K | 0.2% | 104 |
|
|
2025
Q3 | $1.31M | Sell |
17,355
-1,750
| -9% | -$120K | 0.26% | 98 |
|
|
2025
Q2 | $1.32M | Sell |
19,105
-4,225
| -18% | -$277K | 0.28% | 93 |
|
|
2025
Q1 | $1.58M | Sell |
23,330
-700
| -3% | -$41.9K | 0.33% | 77 |
|
|
2024
Q4 | $1.08M | Sell |
24,030
-22,359
| -48% | -$1.25M | 0.22% | 97 |
|
|
2024
Q3 | $2.92M | Sell |
46,389
-3,347
| -7% | -$195K | 0.57% | 48 |
|
|
2024
Q2 | $2.94M | Sell |
49,736
-4,273
| -8% | -$267K | 0.6% | 48 |
|
|
2024
Q1 | $4.31M | Sell |
54,009
-4,593
| -8% | -$351K | 0.66% | 38 |
|
|
2023
Q4 | $4.63M | Sell |
58,602
-822
| -1% | -$58.5K | 0.87% | 27 |
|
|
2023
Q3 | $4.15M | Sell |
59,424
-573
| -1% | -$40.6K | 0.86% | 25 |
|
|
2023
Q2 | $4.15M | Sell |
59,997
-2,263
| -4% | -$161K | 0.83% | 27 |
|
|
2023
Q1 | $4.63M | Sell |
62,260
-1,523
| -2% | -$128K | 0.97% | 24 |
|
|
2022
Q4 | $5.94M | Sell |
63,783
-54
| -0.1% | -$5.21K | 1.3% | 19 |
|
|
2022
Q3 | $6.09M | Sell |
63,837
-4,234
| -6% | -$419K | 1.44% | 17 |
|
|
2022
Q2 | $6.31M | Sell |
68,071
-1,795
| -3% | -$175K | 1.39% | 18 |
|
|
2022
Q1 | $7.07M | Buy |
69,866
+102
| +0.1% | +$10.7K | 1.36% | 18 |
|
|
2021
Q4 | $7.2M | Buy |
69,764
+551
| +0.8% | +$50.9K | 1.35% | 17 |
|
|
2021
Q3 | $5.87M | Buy |
69,213
+301
| +0.4% | +$25.2K | 1.23% | 20 |
|
|
2021
Q2 | $5.75M | Sell |
68,912
-249
| -0.4% | -$20.4K | 1.19% | 21 |
|
|
2021
Q1 | $5.2M | Sell |
69,161
-168
| -0.2% | -$12.2K | 1.15% | 22 |
|
|
2020
Q4 | $4.74M | Buy |
69,329
+8,877
| +15% | +$577K | 1.15% | 21 |
|
|
2020
Q3 | $3.53M | Buy |
60,452
+4,233
| +8% | +$263K | 0.97% | 27 |
|
|
2020
Q2 | $3.65M | Buy |
56,219
+2,505
| +5% | +$158K | 1.08% | 23 |
|
|
2020
Q1 | $3.19M | Buy |
53,714
+7,250
| +16% | +$484K | 1.09% | 23 |
|
|
2019
Q4 | $3.45M | Buy |
46,464
+3,220
| +7% | +$226K | 0.95% | 29 |
|
|
2019
Q3 | $2.73M | Buy |
43,244
+14,709
| +52% | +$872K | 0.81% | 36 |
|
|
2019
Q2 | $1.55M | Buy |
28,535
+10,805
| +61% | +$582K | 0.48% | 66 |
|
|
2019
Q1 | $956K | Buy |
17,730
+4,200
| +31% | +$259K | 0.53% | 62 |
|
|
2018
Q4 | $886K | Hold |
13,530
| – | – | 0.56% | 58 |
|
|
2018
Q3 | $1.06M | Buy |
13,530
+1,650
| +14% | +$118K | 0.59% | 57 |
|
|
2018
Q2 | $764K | Buy |
11,880
+600
| +5% | +$39.5K | 0.45% | 67 |
|
|
2018
Q1 | $701K | Hold |
11,280
| – | – | 0.42% | 69 |
|
|
2017
Q4 | $817K | Sell |
11,280
-85
| -0.7% | -$6.18K | 0.49% | 59 |
|
|
2017
Q3 | $924K | Sell |
11,365
-50
| -0.4% | -$3.96K | 0.62% | 51 |
|
|
2017
Q2 | $918K | Buy |
11,415
+75
| +0.7% | +$5.92K | 0.65% | 48 |
|
|
2017
Q1 | $890K | Buy |
11,340
+6,540
| +136% | +$522K | 0.65% | 48 |
|
|
2016
Q4 | $378K | Buy |
+4,800
| New | +$388K | 0.3% | 81 |
|
Other funds holding CVS
VCM
VPM
Mengis Capital Management's CVS Position: Q1 2026 in Review
Mengis Capital Management reduced its CVS Health (CVS) stake by 4.3% in Q1 2026, selling an estimated $46.2K and leaving 13,394 shares worth $962K. The position accounts for 0.17% of the portfolio, ranked #117.
Mengis Capital Management first reported a position in CVS in Q4 2016 and has held it in 38 quarters since. The position peaked at $7.2M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Mengis Capital Management held 13,394 shares of CVS Health worth $962K as of Q1 2026.
- Mengis Capital Management sold 600 CVS Health shares in Q1 2026, an estimated $46.2K.
- CVS Health made up 0.17% of Mengis Capital Management's portfolio in Q1 2026, its #117 holding.
- Mengis Capital Management first reported a position in CVS Health in Q4 2016 and has held it in 38 quarters since.
- Mengis Capital Management's CVS Health position peaked at $7.2M in Q4 2021.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Mengis Capital Management's 13F filing for Q1 2026, filed 12 May 2026.